Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K11 | Q16584 | 7/20 | 0.53 |
| ▸ | TNIK | Q9UKE5 | 6/20 | 0.48 |
| ▸ | ACACB | O00763 | 1/20 | 0.43 |
| ▸ | ACACA | Q13085 | 1/20 | 0.43 |
| ▸ | IGF1R | P08069 | 2/20 | 0.43 |
| ▸ | IL2 | P60568 | 3/20 | 0.39 |
| ▸ | MAP4K1 | Q92918 | 3/20 | 0.39 |
| ▸ | OTUD7B | Q6GQQ9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30399129 | 1.00 | MAP3K11 (0.53) | MAP3K11TNIKACACBACACAIGF1R | |
| SCHEMBL26174982 | 0.94 | MAP3K11 (0.51) | MAP3K11TNIKACACBACACAIGF1R | |
| SCHEMBL30400509 | 0.94 | MAP3K11 (0.51) | MAP3K11TNIKACACBACACAIGF1R | |
| SCHEMBL26175064 | 0.87 | MAP3K11 (0.43) | MAP3K11TNIKACACBACACAIGF1R | |
| SCHEMBL30400013 | 0.87 | MAP3K11 (0.43) | MAP3K11TNIKACACBACACAIGF1R | |
| SCHEMBL30398693 | 0.87 | MAP3K11 (0.40) | MAP3K11TNIKACACBACACAIL2 | |
| SCHEMBL26175022 | 0.87 | MAP3K11 (0.40) | MAP3K11TNIKACACBACACAIL2 | |
| SCHEMBL30399632 | 0.85 | EGLN1 (0.43) | MAP3K11TNIKIL2MAP4K1 | |
| SCHEMBL26174944 | 0.85 | EGLN1 (0.43) | MAP3K11TNIKIL2MAP4K1 | |
| SCHEMBL26174759 | 0.85 | MAP3K11 (0.44) | MAP3K11TNIKIL2MAP4K1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192686-A1 | 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF | TENARX, INC. | 2023-06-22 | — | — | US | disclosed |
| US-20230192686-A1 | 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF | TENARX, INC. | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192686-A1 | 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF | DYRK1A, DYRK1B, DYRK2 | MAP3K11 72/4885TNIK 500/4885ACACB 2799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.